COVID-19 Infection in Patients with Chronic Lymphocytic Leukemia: Report of Two Cases and Literature Review | ||
| Research in Oncology | ||
| Article 6, Volume 17, Issue 2, December 2021, Pages 80-85 PDF (195.55 K) | ||
| Document Type: Case reports | ||
| DOI: 10.21608/resoncol.2021.51731.1128 | ||
| Authors | ||
| Noha Eisa* 1, 2; Abdulrahman Alshehri1; Mohammed Assiri1 | ||
| 1Hemato-Oncology Department, Aseer Central Hospital, Abha, Saudi Arabia | ||
| 2Clinical Hematology, Faculty of Medicine, Mansoura University, Mansoura, Egypt | ||
| Abstract | ||
| Chronic lymphocytic leukemia (CLL) typically occurs in the elderly and has a highly variable clinical course. Infectious complications have been known to be a major cause of morbidity and mortality in CLL patients. The management of hematological malignancies, including CLL, during the COVID-19 pandemic is challenging. Here we describe two patients with CLL who got infected with SARS-COV-2 as confirmed by positive nasopharyngeal swab PCR. The 1st patient, who was receiving treatment for CLL-associated autoimmune hemolytic anemia, was hospitalized with mild COVID-19 symptoms. The 2nd patient, who was on active treatment for CLL, had asymptomatic COVID-19 infection and was not hospitalized. Both patients recovered from COVID-19 without related complications. | ||
| Keywords | ||
| COVID-19; Chronic Lymphocytic Leukemia; SARS-COV-2 | ||
|
Statistics Article View: 529 PDF Download: 961 |
||
